These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34958985)

  • 1. Clinical Use of A Priori Knowledge of Organ-At-Risk Sparing During Radiation Therapy Treatment for Oropharyngeal Cancer: Dosimetric and Patient Reported Outcome Improvements.
    Fried DV; Das SK; Marks LB; Chera BS
    Pract Radiat Oncol; 2022; 12(3):e193-e200. PubMed ID: 34958985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for a priori estimation of best feasible DVH for organs-at-risk: Validation for head and neck VMAT planning.
    Ahmed S; Nelms B; Gintz D; Caudell J; Zhang G; Moros EG; Feygelman V
    Med Phys; 2017 Oct; 44(10):5486-5497. PubMed ID: 28777469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
    Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact.
    Verbakel WFAR; Doornaert PAH; Raaijmakers CPJ; Bos LJ; Essers M; van de Kamer JB; Dahele M; Terhaard CHJ; Kaanders JHAM
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):514-524. PubMed ID: 31306734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of PlanIQ Feasibility DVH for head and neck treatment planning.
    Fried DV; Chera BS; Das SK
    J Appl Clin Med Phys; 2017 Sep; 18(5):245-250. PubMed ID: 28857470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.
    Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.
    Hunter KU; Fernandes LL; Vineberg KA; McShan D; Antonuk AE; Cornwall C; Feng M; Schipper MJ; Balter JM; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):676-82. PubMed ID: 24035328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning.
    Wu B; Ricchetti F; Sanguineti G; Kazhdan M; Simari P; Jacques R; Taylor R; McNutt T
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1241-7. PubMed ID: 20800382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semiautomated head-and-neck IMRT planning using dose warping and scaling to robustly adapt plans in a knowledge database containing potentially suboptimal plans.
    Schmidt M; Lo JY; Grzetic S; Lutzky C; Brizel DM; Das SK
    Med Phys; 2015 Aug; 42(8):4428-34. PubMed ID: 26233173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric-modulated arc therapy (VMAT) for whole brain radiotherapy: not only for hippocampal sparing, but also for reduction of dose to organs at risk.
    Sood S; Pokhrel D; McClinton C; Lominska C; Badkul R; Jiang H; Wang F
    Med Dosim; 2017 Winter; 42(4):375-383. PubMed ID: 28822604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using feasibility dose-volume histograms to reduce intercampus plan quality variability for head-and-neck cancer.
    Ahmed S; Liu CW; LaHurd D; Murray E; Kolar M; Joshi N; Woody N; Koyfman S; Xia P
    J Appl Clin Med Phys; 2023 Jan; 24(1):e13749. PubMed ID: 35962566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: an intertechnique and interinstitutional study.
    Lian J; Yuan L; Ge Y; Chera BS; Yoo DP; Chang S; Yin F; Wu QJ
    Med Phys; 2013 Dec; 40(12):121704. PubMed ID: 24320490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal tissue anatomy for oropharyngeal cancer: contouring variability and its impact on optimization.
    Feng M; Demiroz C; Vineberg KA; Eisbruch A; Balter JM
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e245-9. PubMed ID: 22583602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.
    Arbab M; Chen YH; Tishler RB; Gunasti L; Glass J; Fugazzotto JA; Killoran JH; Sethi R; Rettig E; Annino D; Goguen L; Uppaluri R; Hsu C; Burke E; Hanna GJ; Lorch J; Haddad RI; Margalit DN; Schoenfeld JD
    Head Neck; 2022 Jun; 44(6):1442-1452. PubMed ID: 35355358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward optimal organ at risk sparing in complex volumetric modulated arc therapy: an exponential trade-off with target volume dose homogeneity.
    Tol JP; Dahele M; Doornaert P; Slotman BJ; Verbakel WF
    Med Phys; 2014 Feb; 41(2):021722. PubMed ID: 24506613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.